Secoisolariciresinol diglucoside inhibits imiquimod-induced psoriatic inflammation in mice
Secoisolariciresinol diglucoside(SDG) attenuated psoriatic skin lesions. The mice skin were detected by transcriptomics to identify the therapeutic mechanism of SDG.